drugset / Trial / NCT00883740

Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia

NCT00883740 ↗

Phase 3 Completed 119 enrolled Viatris Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to demonstrate the effect of Lyrica on Wake after sleep onset in subjects with fibromyalgia with sleep maintenance disturbance (on polysomnogram)

Timeline

Start
2009-06
Primary completion
2010-06
Completion
2010-06

Outcome

Met primary endpoint

registry analysis (unspecified test); Placebo vs Pregabalin; p <0.0001; Mean Difference (Final Values) -19.15 (95% CI -26.69 to -11.61) NCT00883740 ↗

paper Patients treated with pregabalin showed a reduction in PSG-determined WASO versus treatment with placebo PMID 22232085 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 300 mg —
Subject Pregabalin Small molecule 450 mg —